http___bg.gsk.com_bg-bg__D0_B7_D0_B0-_D0_BD_D0_B0_D1_81__D1_81-_D0_BA_D0_B0_D0_BA_D0_B2_D0_BE-_D1_81_D0_B5-_D0_B7_D0_B0_D0_BD_D0_B8_D0_BC_D0_B0_D0_B2_D0_B0_D0_BC_D0_B5__1.xml
1.1 2.1 2.2 3.1 3.2 4.1
С какво се занимаваме Ние сме водена от науката глобална компания в сферата на здравеопазването. Изследваме и разработваме широк набор от иновативни продукти в три основни области: лекарства по лекарско предписание, ваксини и продукти без рецепта. Ние сме водена от науката глобална компания в сферата на здравеопазването. Изследваме и разработваме широк набор от иновативни продукти в три основни области: лекарства по лекарско предписание, ваксини и продукти без рецепта. Също така, имаме значително глобално присъствие с търговска дейност в повече от 150 страни, с мрежа от 89 производствени обекта и големи центрове за научноизследователска и развойна дейност във Великобритания, САЩ, Белгия и Китай.
1.1 2.1 2.2 3.1 4.1 5.1 5.2 6.1 7.1 8.1 8.2 8.3 9.1 10.1 11.1 11.2 11.3 12.1
What we do We are a science-led global healthcare company. We research and develop a broad range of innovative products in three primary areas of Pharmaceuticals, Vaccines and Consumer Healthcare. We have a significant global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large R&D centres in the UK, USA, Spain, Belgium and China. Pharmaceuticals Our pharmaceuticals business develops and makes medicines to treat a broad range of acute and chronic diseases. In Singapore, our portfolio is made up of both patent-protected and off-patent medicines. £15.5bn turnover, 67% of Group Vaccines Our vaccines business is one of the largest in the world, producing paediatric and adult vaccines against a range of infectious diseases. In 2014, we distributed more than 800 million doses to 170 countries, of which over 80% were supplied to developing countries. On completion of the transfer of HIB (Haemophilus Influenzae type B) production to Tuas, Singapore will be responsible for more than 20% of GSK's total vaccines production. £3.2bn turnover, 14% of Group Consumer Healthcare We develop and market a range of consumer healthcare products based on scientific innovation. We have brands in four main categories: Wellness, Oral health, Skin health and Nutrition. In Singapore, our top brands in each category are Panadol, Sensodyne, Physiogel and Horlicks. £4.3bn turnover, 19% of Group